Education
About Us
Working with TipRanks
Follow Us
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Earnings Data
Report Date
Feb 09, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.77Last Year’s EPS
-1.05Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mixed sentiment with significant advancements in the RSV and immunology programs and a stable financial position. However, it also highlighted challenges with a decline in revenue, increased net loss, and slower enrollment in the RSVPEDs study.Company Guidance
RSV Program Advancements
Progress in developing the first oral antiviral treatment for RSV, with two Phase II studies (RSVPEDs and RSVHR) ongoing and anticipation of reporting data in the second half of 2024.
Successful EDP-323 Development
EDP-323 is in a Phase IIa challenge study with anticipated data in Q3 2024, supported by positive Phase I results demonstrating favorable safety and pharmacokinetics.
Pipeline Expansion into Immunology
Introduction of a new immunology program targeting chronic spontaneous urticaria (CSU) with a goal to select a development candidate by Q4 2024.
Stable Financial Position
Enanta ended the quarter with approximately $300 million in cash and marketable securities, projecting sufficient funds to meet anticipated needs through Q3 2027.
ENTA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ENTA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 17, 2025 | $12.82 | $12.36 | -3.59% |
Aug 11, 2025 | $6.49 | $6.86 | +5.70% |
May 12, 2025 | $5.55 | $5.23 | -5.77% |
Feb 10, 2025 | $4.90 | $5.59 | +14.08% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Enanta Pharmaceuticals (ENTA) report earnings?
Enanta Pharmaceuticals (ENTA) is schdueled to report earning on Feb 09, 2026, After Close (Confirmed).
What is Enanta Pharmaceuticals (ENTA) earnings time?
Enanta Pharmaceuticals (ENTA) earnings time is at Feb 09, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ENTA EPS forecast?
ENTA EPS forecast for the fiscal quarter 2026 (Q1) is -0.77.
